|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
26 October 2021 |
|
Main ID: |
NCT01329224 |
|
Date of registration:
|
30/03/2011 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
The Antiaggregation Monitoring (TAM) Registry
TAM |
|
Scientific title:
|
Acetylsalicylic Acid in Outpatient Practice - Results From The Antiaggregation Monitoring (TAM) Registry |
|
Date of first enrolment:
|
November 2010 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT01329224 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Switzerland
| | | | | | | |
|
Contacts
|
|
Name:
|
Stéphane Cook, Prof |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Fribourg University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients under chronic ASA treatment for more then one month
Exclusion Criteria:
- concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs)
- thrombocytopenia
- thrombocytosis
- age <18 years
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Aspirin Causing Adverse Effects in Therapeutic Use
|
|
Intervention(s)
|
|
Other: Measurement of platelet anti-aggregation
|
|
Primary Outcome(s)
|
|
Whole blood impedance platelet aggregometry to assess acetylsalicylic acid resistance rates
[Time Frame: 6 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|